Your browser doesn't support javascript.
loading
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blombery, Piers; Lew, Thomas E; Dengler, Michael A; Thompson, Ella R; Lin, Victor S; Chen, Xiangting; Nguyen, Tamia; Panigrahi, Ashish; Handunnetti, Sasanka M; Carney, Dennis A; Westerman, David A; Tam, Constantine S; Adams, Jerry M; Wei, Andrew H; Huang, David C S; Seymour, John F; Roberts, Andrew W; Anderson, Mary Ann.
Affiliation
  • Blombery P; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Lew TE; University of Melbourne, Melbourne, VIC, Australia.
  • Dengler MA; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Thompson ER; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Lin VS; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Chen X; University of Melbourne, Melbourne, VIC, Australia.
  • Nguyen T; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Panigrahi A; Division on Oncology, Medical University of Graz, Graz, Austria; and.
  • Handunnetti SM; University of Melbourne, Melbourne, VIC, Australia.
  • Carney DA; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Westerman DA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Tam CS; University of Melbourne, Melbourne, VIC, Australia.
  • Adams JM; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Wei AH; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Huang DCS; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Seymour JF; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Roberts AW; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Anderson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Blood ; 139(8): 1198-1207, 2022 02 24.
Article in En | MEDLINE | ID: mdl-34469514
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary / Bridged Bicyclo Compounds, Heterocyclic / Hematologic Neoplasms / Myelopoiesis / Bcl-2-Associated X Protein / Mutation / Myeloproliferative Disorders Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2022 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary / Bridged Bicyclo Compounds, Heterocyclic / Hematologic Neoplasms / Myelopoiesis / Bcl-2-Associated X Protein / Mutation / Myeloproliferative Disorders Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2022 Type: Article Affiliation country: Australia